LONG TERM FOLLOW UP OF LOCALIZED, PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB AND CHOP

被引：0
|
作者：
Kobayashi, Y. [1 ]
Hatta, Y. [1 ]
Hojo, A. [1 ]
Kura, Y. [2 ]
Miura, K. [1 ]
Iriyama, N. [1 ]
Kobayashi, S. [1 ]
Sawada, U. [2 ]
Sugitani, M. [3 ]
Takeuchi, J. [1 ]
机构：
[1] Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Tokyo, Japan
[2] Kasukabe Municipal Hosp, Dept Hematol & Oncol, Saitama, Japan
[3] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [21] NO BENEFIT OF ADDING RITUXIMAB TO CHOP REGIMEN IN PATIENTS WITH PRIMARY EXTRANODAL TYPE OF DIFFUSE LARGE B-CELL LYMPHOMA
    Jang, G.
    Kim, S. W.
    Kim, S.
    Lee, D. H.
    Huh, J.
    Kim, H. J.
    Suh, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 559 - 559
  • [22] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
  • [23] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [24] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Moonho Kim
    Yongchel Ahn
    Heui-June Ahn
    Suk-Hun Ha
    Ho-Suk Oh
    Jae-Seok Song
    Woong-Sub Park
    Sang-Wook Yi
    Annals of Hematology, 2023, 102 : 3167 - 3175
  • [25] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Moonho
    Ahn, Yongchel
    Ahn, Heui-June
    Ha, Suk-Hun
    Oh, Ho-Suk
    Song, Jae-Seok
    Park, Woong-Sub
    Yi, Sang-Wook
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3167 - 3175
  • [26] Rituximab, bevacizumab (avastin) and CHOP (RA-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL).
    Ganjoo, KN
    Gordon, L
    Robertson, MJ
    Horning, SJ
    BLOOD, 2004, 104 (11) : 389A - 389A
  • [27] Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
    Park, Silvia
    Han, Boram
    Cho, Jae Won
    Woo, Sook-young
    Kim, Seonwoo
    Kim, Seok Jin
    Kim, Won Seog
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (02): : 225 - 233
  • [28] Addition of rituximab to CHOP regimen demonstrates improved outcome of diffuse large B-cell lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 4 (03): : 142 - 144
  • [29] Surgical Resection and Rituximab Show No Benefit in the Treatment of Primary Gastric Diffuse Large B-Cell Lymphoma
    Huang, Haiwen
    Fu, Tianwen
    Wang, Qiangli
    Xu, Ting
    Chen, Xiaochen
    Jin, Zhengming
    Wu Depei
    BLOOD, 2015, 126 (23)
  • [30] Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
    Younes, Anas
    Burke, John M.
    Cheson, Bruce D.
    Diefenbach, Catherine S.
    Ferrari, Silvia
    Hahn, Uwe H.
    Hawkes, Eliza A.
    Khan, Cyrus
    Lossos, Izidore S.
    Musuraca, Gerardo
    Tani, Monica
    Vitolo, Umberto
    Yuen, Sam
    Raval, Aparna
    Shivhare, Mahesh
    Nielsen, Tina G.
    Sellam, Gila
    Sharman, Jeff P.
    BLOOD ADVANCES, 2023, 7 (08) : 1488 - 1495
12345